The West Nile Virus IgG IgM Antibodies Test measures immune response to West Nile virus, distinguishing recent from prior infection. IgM levels indicate active or recent illness, while IgG reflects past exposure or long-term immunity. This test aids in evaluating unexplained fever, flu-like symptoms, or neurological complications, supporting assessment of vector-borne viral infection and systemic health.

The Respiratory Allergy Panel Region 17 measures IgE antibodies to common allergens, including molds (Alternaria, Aspergillus, Cladosporium, Penicillium), grasses (timothy), trees (alder, birch, oak, walnut, cedar, elm, maple, cottonwood, white ash), weeds (ragweed, pigweed, nettle, sheep sorrel), and indoor allergens (cat and dog dander, dust mites, cockroach, mouse proteins). This panel helps identify respiratory allergy triggers.

The Mumps Virus Titer Test measures IgG antibodies to determine immunity from prior infection or vaccination. A positive result indicates protective immunity, while a negative result suggests susceptibility to mumps. Doctors use this blood test to confirm immune status, check vaccine response, or meet school, travel, or employment requirements. It provides valuable information for individual protection and public health safety.

The Epstein-Barr Virus (EBV) Comprehensive Panel measures VCA IgM, VCA IgG, EBNA IgG, and Early Antigen D IgG antibodies to evaluate stage of EBV infection. This virus causes mononucleosis and has links to chronic fatigue, autoimmune conditions, and certain cancers. Doctors order this test for patients with fever, sore throat, lymph node swelling, or prolonged fatigue. Results help distinguish acute, past, or reactivated EBV infection and guide clinical care.

The Herpes Virus 6 DNA Test detects HHV-6 DNA in blood or tissue to evaluate active infection or viral reactivation. Human herpesvirus 6 is associated with roseola in children and has been linked to encephalitis, seizures, myocarditis, chronic fatigue, and transplant complications. This molecular test helps assess viral load, monitor disease progression, and guide evaluation of neurological and immunological conditions.

The Zika Virus RNA Qualitative Test detects the genetic material of the Zika virus in blood or other specimens using molecular amplification. This test identifies active infection during the acute phase, helping confirm Zika virus exposure and guide clinical management. It is especially useful in evaluating febrile illness, pregnancy-related risk, and travel-associated viral infections.

The Coxsackie B Virus Antibodies test is a diagnostic blood test used to detect antibodies produced by the immune system in response to a Coxsackie B virus infection. Coxsackie B viruses belong to the enterovirus family and are associated with a range of illnesses, from mild flu-like symptoms to more severe conditions such as viral myocarditis and meningitis. This test measures the presence of specific antibodies against Coxsackie B viruses, helping to confirm recent or past infections and assess the immune response to the virus. The test is particularly useful in identifying cases where Coxsackie B virus may be the underlying cause of unexplained cardiac, neurological, or systemic symptoms.

The Epstein-Barr Virus Antibody (EBV) Panel detects antibodies to EBV, including VCA IgM, VCA IgG, and EBNA IgG, to determine current, recent, or past infection. EBV causes infectious mononucleosis and has links to chronic fatigue and certain cancers. Doctors order this test for patients with fever, sore throat, swollen lymph nodes, or fatigue. Results help identify stage of infection, confirm diagnosis, and guide clinical management of EBV-related illness.

The Quantitative Epstein-Barr Virus (EBV) DNA Real-Time PCR Test measures the amount of EBV genetic material in blood to monitor viral load. Unlike antibody tests, it directly tracks EBV activity, making it vital for transplant patients, immunocompromised individuals, or those with chronic EBV. Doctors order this test to evaluate risk of complications, guide treatment, and monitor response to therapy by quantifying EBV levels over time.

The Hepatitis B Virus DNA Quantitative Test measures the amount of HBV genetic material in blood to determine viral load. This test helps evaluate disease activity, monitor progression of acute or chronic hepatitis B, and assess treatment response. High viral load indicates active replication, while low or undetectable levels suggest controlled infection. Doctors use it to guide antiviral therapy, track treatment effectiveness, and manage long-term liver health.

The Herpes Virus 6 IgG IgM Antibodies Test detects immune response to HHV-6, a virus linked to roseola and other illnesses. IgM antibodies suggest recent or acute infection, while IgG indicates past exposure or reactivation. This test supports evaluation of fever, rash, or neurologic symptoms and may help identify complications in immunocompromised patients, providing valuable insight into HHV-6 infection status and immune activity.